Serum erythropoietic inhibitors in patients with pure red cell aplasia. 1991

M Takahashi, and K Nikkuni, and I Tanaka, and T Furukawa, and Y Moriyama, and A Shibata, and S Satoh, and Y Kuwabara, and Y Maruyama, and Y Matsunaga
First Department of Internal Medicine, Niigata University, Japan.

Inhibitory mechanisms of erythropoiesis in 20 patients with pure red cell aplasia (PRCA) were investigated using the technique of in vitro hematopoiesis and an assay for human parvovirus. Complement-dependent serum inhibitors against late erythroid progenitors (CFU-E) were demonstrated in seven of 19 patients examined, and complement-dependent inhibitors against early erythroid progenitors (BFU-E) were demonstrated in three of these seven patients. Nonspecific and complement-independent inhibitors against CFU-E were thought to be associated with the etiology of PRCA in one patient. Human parvovirus-mediated erythropoietic suppression was demonstrated in a patient with complete remission of acute lymphoblastic leukemia complicated with marrow erythroid aplasia, whose serum showed a perfect inhibition against erythroid progenitor cells. T-cell-mediated erythroid suppression was not demonstrated in the patients examined. These findings reveal that erythroid aplasia is associated with complement-dependent serum erythropoietic inhibitor in some patients (36.8% in the present study) with PRCA, but it is difficult to identify the mechanism of erythroid aplasia in more than half of the patients with PRCA. In addition, our present study discovered the presence of parvovirus-mediated marrow pure red cell aplasia in one adult patient with acute lymphoblastic leukemia.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010321 Parvoviridae A family of very small DNA viruses containing a single molecule of single-stranded DNA and consisting of two subfamilies: PARVOVIRINAE and DENSOVIRINAE. They infect both vertebrates and invertebrates. Picodnaviruses
D012010 Red-Cell Aplasia, Pure Suppression of erythropoiesis with little or no abnormality of leukocyte or platelet production. Aplasia Pure Red Cell,Erythrocyte Aplasia,Pure Red-Cell Aplasia,Aplasia, Erythrocyte,Aplasia, Pure Red-Cell,Aplasias, Erythrocyte,Erythrocyte Aplasias,Pure Red Cell Aplasia,Pure Red-Cell Aplasias,Red Cell Aplasia, Pure,Red-Cell Aplasias, Pure
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003114 Colony-Forming Units Assay A cytologic technique for measuring the functional capacity of stem cells by assaying their activity. Clonogenic Cell Assay,Stem Cell Assay,Clonogenic Cell Assays,Colony Forming Units Assays,Colony-Forming Units Assays,Stem Cell Assays,Assay, Clonogenic Cell,Assay, Colony-Forming Units,Assay, Stem Cell,Assays, Clonogenic Cell,Assays, Colony-Forming Units,Assays, Stem Cell,Colony Forming Units Assay
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271

Related Publications

M Takahashi, and K Nikkuni, and I Tanaka, and T Furukawa, and Y Moriyama, and A Shibata, and S Satoh, and Y Kuwabara, and Y Maruyama, and Y Matsunaga
February 1975, The Journal of pediatrics,
M Takahashi, and K Nikkuni, and I Tanaka, and T Furukawa, and Y Moriyama, and A Shibata, and S Satoh, and Y Kuwabara, and Y Maruyama, and Y Matsunaga
January 1994, Ryoikibetsu shokogun shirizu,
M Takahashi, and K Nikkuni, and I Tanaka, and T Furukawa, and Y Moriyama, and A Shibata, and S Satoh, and Y Kuwabara, and Y Maruyama, and Y Matsunaga
July 1978, The Quarterly journal of medicine,
M Takahashi, and K Nikkuni, and I Tanaka, and T Furukawa, and Y Moriyama, and A Shibata, and S Satoh, and Y Kuwabara, and Y Maruyama, and Y Matsunaga
August 1976, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
M Takahashi, and K Nikkuni, and I Tanaka, and T Furukawa, and Y Moriyama, and A Shibata, and S Satoh, and Y Kuwabara, and Y Maruyama, and Y Matsunaga
July 1976, Pahlavi medical journal,
M Takahashi, and K Nikkuni, and I Tanaka, and T Furukawa, and Y Moriyama, and A Shibata, and S Satoh, and Y Kuwabara, and Y Maruyama, and Y Matsunaga
January 1981, Harefuah,
M Takahashi, and K Nikkuni, and I Tanaka, and T Furukawa, and Y Moriyama, and A Shibata, and S Satoh, and Y Kuwabara, and Y Maruyama, and Y Matsunaga
July 1983, British journal of haematology,
M Takahashi, and K Nikkuni, and I Tanaka, and T Furukawa, and Y Moriyama, and A Shibata, and S Satoh, and Y Kuwabara, and Y Maruyama, and Y Matsunaga
December 2016, Hematology. American Society of Hematology. Education Program,
M Takahashi, and K Nikkuni, and I Tanaka, and T Furukawa, and Y Moriyama, and A Shibata, and S Satoh, and Y Kuwabara, and Y Maruyama, and Y Matsunaga
April 1990, Indian pediatrics,
M Takahashi, and K Nikkuni, and I Tanaka, and T Furukawa, and Y Moriyama, and A Shibata, and S Satoh, and Y Kuwabara, and Y Maruyama, and Y Matsunaga
November 2016, Blood,
Copied contents to your clipboard!